Novartis AG - Asset Resilience Ratio

Latest as of December 2025: 0.09%

Novartis AG (NVSN) has an Asset Resilience Ratio of 0.09% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read NVSN liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

MX$98.00 Million

≈ $5.64 Million USD Cash + Short-term Investments

Total Assets

MX$110.95 Billion

≈ $6.39 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Novartis AG's Asset Resilience Ratio has changed over time. For market capitalisation and broader financial context, see NVSN company net worth.

Liquid Assets Composition Over Time

This chart breaks down Novartis AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	MX$0.00	0%
Short-term Investments	MX$98.00 Million	0.09%
Total Liquid Assets	MX$98.00 Million	0.09%

Asset Resilience Insights

Limited Liquidity: Novartis AG maintains only 0.09% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Novartis AG Industry Peers by Asset Resilience Ratio

Compare Novartis AG's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
AbbVie Inc NYSE:ABBV	Drug Manufacturers - General	0.02%
Novartis AG SW:NOVN	Drug Manufacturers - General	10.04%
Chongqing Lummy Pharmaceutical SHE:300006	Drug Manufacturers - General	-0.19%
Hangzhou Minsheng Healthcare Co Ltd SHE:301507	Drug Manufacturers - General	24.96%
Zhejiang Zhenyuan Share Co Ltd SHE:000705	Drug Manufacturers - General	5.75%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%
Novartis AG ADR NYSE:NVS	Drug Manufacturers - General	10.03%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	8.63%

Annual Asset Resilience Ratio for Novartis AG (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Novartis AG.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.09%	MX$98.00 Million ≈ $5.64 Million	MX$110.95 Billion ≈ $6.39 Billion	-1.76pp
2024-12-31	1.85%	MX$1.89 Billion ≈ $108.89 Million	MX$102.25 Billion ≈ $5.88 Billion	+1.28pp
2023-12-31	0.57%	MX$569.00 Million ≈ $32.75 Million	MX$99.94 Billion ≈ $5.75 Billion	-9.15pp
2022-12-31	9.72%	MX$11.41 Billion ≈ $656.82 Million	MX$117.45 Billion ≈ $6.76 Billion	-2.20pp
2021-12-31	11.92%	MX$15.71 Billion ≈ $903.89 Million	MX$131.79 Billion ≈ $7.58 Billion	+10.47pp
2020-12-31	1.44%	MX$1.91 Billion ≈ $109.63 Million	MX$132.06 Billion ≈ $7.60 Billion	+1.16pp
2019-12-31	0.28%	MX$334.00 Million ≈ $19.22 Million	MX$118.37 Billion ≈ $6.81 Billion	-1.57pp
2018-12-31	1.85%	MX$2.69 Billion ≈ $154.98 Million	MX$145.56 Billion ≈ $8.38 Billion	+1.38pp
2017-12-31	0.47%	MX$625.00 Million ≈ $35.97 Million	MX$133.08 Billion ≈ $7.66 Billion	-0.12pp
2016-12-31	0.59%	MX$770.00 Million ≈ $44.31 Million	MX$130.12 Billion ≈ $7.49 Billion	+0.11pp
2015-12-31	0.48%	MX$630.00 Million ≈ $36.26 Million	MX$131.56 Billion ≈ $7.57 Billion	+0.09pp
2014-12-31	0.39%	MX$483.00 Million ≈ $27.80 Million	MX$125.39 Billion ≈ $7.22 Billion	--

pp = percentage points

About Novartis AG

MX:NVSN Mexico Drug Manufacturers - General

Market Cap

$288.37 Billion

MX$5.01 Trillion MXN

Market Cap Rank

#55 Global

#2 in Mexico

Share Price

MX$2626.00

Change (1 day)

+1.43%

52-Week Range

MX$2092.19 - MX$2866.83

All Time High

MX$2866.83